Ty McClure

Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial

Craig Campbell, Hugh J. McMillan, Jean K. Mah et al. · Muscle & Nerve · 2016 · 234 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

A phase 1 study of ACE‐536, a regulator of erythroid differentiation, in healthy volunteers

Kenneth M. Attie, Mark Allison, Ty McClure et al. · American Journal of Hematology · 2014 · 108 citations · Full text

Medicine, Hematology, Pharmacology +13

Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

Lala M. Dunbar, Joe Milata, Ty McClure et al. · Antimicrobial Agents and Chemotherapy · 2011 · 64 citations

Medicine, Pharmacokinetics, Pharmacology +17

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer

Johanna C. Bendell, Michael S. Gordon, Herbert I. Hurwitz et al. · Clinical Cancer Research · 2013 · 60 citations

Medicine, Oncology, Pharmacology +16

Effects of molybdenum intake on primary infection and subsequent challenge by the nematode parasiteTrichostrongylus colubriformisin weaned Merino lambs

S.J. McClure, Ty McClure, D.L. Emery · Research in Veterinary Science · 1999 · 31 citations

Veterinary Medicine, Biology, Zoology +17